Literature DB >> 26339851

Endonasal endoscopic transsphenoidal chiasmapexy using a clival cranial base cranioplasty for visual loss from massive empty sella following macroprolactinoma treatment with bromocriptine: case report.

G Rene Alvarez Berastegui1, Shaan M Raza1, Vijay K Anand2, Theodore H Schwartz1,2,3.   

Abstract

Visual deterioration after dopamine-agonist treatment of prolactinomas associated with empty sella syndrome and secondary optic apparatus traction is a rare event. Chiasmapexy has been described as a viable treatment option, although few cases exist in the literature. Here, a novel endonasal endoscopic approach to chiasmapexy is described and its efficacy is demonstrated in a case report. A 55-year-old female patient with a history of a giant prolactinoma and 14 years of treatment using dopaminergic agonist therapy presented to our institution with a 1-month history of visual changes. Neuroophthalmological examination confirmed severe bitemporal field defects, and MRI revealed a large empty sella with downward optic chiasmal herniation. Endoscopic endonasal chiasmapexy was performed by elevating the chiasm with lumbar drainage and filling the clival and sellar defect with an extradural liquid (HydroSet; a cranioplasty bone cement), and a piece of AlloDerm was used to cover and cushion the chiasm. Postoperative imaging demonstrated successful anatomical elevation of the optic apparatus, and the patient showed functional improvement in the visual field at 3 months postoperatively. Although rare, massive empty sellar and chiasmal descent from macroadenoma treatment can result in progressive visual loss. Here, a novel technique of endonasal endoscopic extradural cranioplasty aided by lumbar drainage is reported, which appears to be an effective technique for stabilizing and possibly reversing anatomical and visual deterioration.

Entities:  

Keywords:  ACoA = anterior communicating artery; CTA = CT angiography; bromocriptine; chiasmapexy; empty sella; endonasal; endoscopic; pituitary surgery; plasty; prolactinoma; transsphenoidal

Mesh:

Substances:

Year:  2015        PMID: 26339851     DOI: 10.3171/2015.2.JNS142015

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

1.  Acellular dermal matrix as an alternative to autologous fascia lata for skull base repair following extended endoscopic endonasal approaches.

Authors:  Brett E Youngerman; Jennifer A Kosty; Mina M Gerges; Abtin Tabaee; Ashutosh Kacker; Vijay K Anand; Theodore H Schwartz
Journal:  Acta Neurochir (Wien)       Date:  2020-02-11       Impact factor: 2.216

2.  3D printing and intraoperative neuronavigation tailoring for skull base reconstruction after extended endoscopic endonasal surgery: proof of concept.

Authors:  Walid I Essayed; Prashin Unadkat; Ahmed Hosny; Sarah Frisken; Marcio S Rassi; Srinivasan Mukundan; James C Weaver; Ossama Al-Mefty; Alexandra J Golby; Ian F Dunn
Journal:  J Neurosurg       Date:  2018-03-02       Impact factor: 5.115

Review 3.  Chiasmapexy for secondary empty sella syndrome: diagnostic and therapeutic considerations.

Authors:  Thomas Graillon; Thibault Passeri; Mohamed Boucekine; Mikael Meyer; Rosaria Abritti; Anne-Laure Bernat; Moujahed Labidi; Henry Dufour; Sébastien Froelich
Journal:  Pituitary       Date:  2020-11-02       Impact factor: 4.107

Review 4.  Treatment of empty sella associated with visual impairment: a systematic review of chiasmapexy techniques.

Authors:  Lina Raffaella Barzaghi; Carmine Antonio Donofrio; Pietro Panni; Marco Losa; Pietro Mortini
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

5.  Empty Sella Syndrome as a Window Into the Neuroprotective Effects of Prolactin.

Authors:  David A Paul; Emma Strawderman; Alejandra Rodriguez; Ricky Hoang; Colleen L Schneider; Sam Haber; Benjamin L Chernoff; Ismat Shafiq; Zoë R Williams; G Edward Vates; Bradford Z Mahon
Journal:  Front Med (Lausanne)       Date:  2021-07-08

6.  Chiasmal herniation following treatment of pituitary macroadenoma.

Authors:  Marjolein Tabak; Iris C M Pelsma; Mark C Kruit; Wouter R van Furth; Nienke R Biermasz; Irene C Notting
Journal:  Pituitary       Date:  2020-10-15       Impact factor: 4.107

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.